期刊文献+

Subchondral bone grafting reduces degenerative change of knee joint in patients of giant cell tumor of bone 被引量:11

Subchondral bone grafting reduces degenerative change of knee joint in patients of giant cell tumor of bone
原文传递
导出
摘要 Background Giant cell tumors (GCTs) most commonly occur around the knee.The most beneficial procedure for this disease has been extensive curettage with reconstruction.However,since many GCTs may compromise the subchondral bone,surgery can further jeopardize the articular cartilage and result in secondary osteoarthritis.In this study,we aimed to determine the factors associated with the development of degenerative arthritis and the effect of bone grafting on the prevention of secondary osteoarthritis.Methods We retrospectively analyzed 76 patients with GCT around the knee.The mean age at first diagnosis was 31.1 years.Surgical treatments included extensive curettage and cementation with or without bone grafting in the subchondral bone.Patient follow-up was a median duration of 35 months,ranging from 18 to 113 months.Results The local recurrence rate was 5.3% (4/76).Secondary degenerative changes occurred in 30.3% (23/76) of the patients.Less than 10 mm of the residual thickness of the remaining subchondral bone was correlated with secondary degenerative changes in 57 patients (P <0.001).Of these 57 patients,56.5% (13/23) treated with bone cement reconstruction alone developed secondary degenerative changes; following bone grafting,the rate decreased to 29.4%(10/34),with a statistically significant difference (P=0.041).Conclusions GCT patients with less residual thickness of the subchondral bone are more likely to develop degenerative arthritis after curettage.Bone grafting in the subchondral bone area is recommended when the residual thickness of the subchondral bone is less than 10 mm. Background Giant cell tumors (GCTs) most commonly occur around the knee.The most beneficial procedure for this disease has been extensive curettage with reconstruction.However,since many GCTs may compromise the subchondral bone,surgery can further jeopardize the articular cartilage and result in secondary osteoarthritis.In this study,we aimed to determine the factors associated with the development of degenerative arthritis and the effect of bone grafting on the prevention of secondary osteoarthritis.Methods We retrospectively analyzed 76 patients with GCT around the knee.The mean age at first diagnosis was 31.1 years.Surgical treatments included extensive curettage and cementation with or without bone grafting in the subchondral bone.Patient follow-up was a median duration of 35 months,ranging from 18 to 113 months.Results The local recurrence rate was 5.3% (4/76).Secondary degenerative changes occurred in 30.3% (23/76) of the patients.Less than 10 mm of the residual thickness of the remaining subchondral bone was correlated with secondary degenerative changes in 57 patients (P <0.001).Of these 57 patients,56.5% (13/23) treated with bone cement reconstruction alone developed secondary degenerative changes; following bone grafting,the rate decreased to 29.4%(10/34),with a statistically significant difference (P=0.041).Conclusions GCT patients with less residual thickness of the subchondral bone are more likely to develop degenerative arthritis after curettage.Bone grafting in the subchondral bone area is recommended when the residual thickness of the subchondral bone is less than 10 mm.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第16期3053-3056,共4页 中华医学杂志(英文版)
关键词 giant cell tumor bone grafting secondary osteoarthritis KNEE giant cell tumor bone grafting secondary osteoarthritis knee
  • 相关文献

参考文献21

  • 1Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am 2012; 94: 461-467.
  • 2Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, et al. Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev 2010; 36: 1-7.
  • 3Campanacci M. Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. 2nd ed. New York, NY: Springer; 1999.
  • 4Muscolo DL, Ayerza MA, Calabrese ME, Gruenberg M. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg Am 1993; 75: 1656- 1662.
  • 5Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg J6rgensen P et al. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Joint Surg Br 2006; 88:531-535.
  • 6Bini SA, Gill K, Johnston JO. Giant cell tumor of bone. Curettage and cement reconstruction. Clin Orthop Relat Res 1995; (321): 245-250.
  • 7Suzuki Y, Nishida Y, Yamada Y, Tsukushi S, Sugiura H, Nakashima H, et al. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone. Knee 2007; 14: 369-374.
  • 8Chen TH, Su YP, Chen WM. Giant cell tumors of the knee: subchondral bone integrity affects the outcome. Int Orthop 2005; 29: 30-34.
  • 9Aboulafia A J, Rosenbaum DH, Sicard-Rosenbaum L, Jelinek JS, Malawer MM. Treatment of large subchondral tumors of the knee with cryosurgery and composite reconstruction. Clin Orthop Relat Res 1994; (307): 189-199.
  • 10Wouters HW. Giant cell tumor of the distal end of the femur with intra-articular fracture of the knee. Treatment by excochleation and filling with bone cement. Rev Chir Orthop Reparatrice Appar Mot 1974; 60(Suppl 2): 316.

同被引文献60

引证文献11

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部